Glass House Brands (GLAS) Amortization of Deferred Charges (2020 - 2026)

Glass House Brands' (GLAS) quarterly Amortization of Deferred Charges came in at $275000.0 in Q1 2026, down 34.21% year-on-year from $418000.0 in Q1 2025, and down 58.46% on a QoQ basis from $662000.0 in Q4 2025.

Glass House Brands (GLAS) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Amortization of Deferred Charges data on file, last reported at $275000.0 in Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges fell 34.21% year-over-year to $275000.0 in Q1 2026; TTM through Mar 2026 was $1.6 million, a 37.59% decrease from a year earlier, with the FY2025 full-year figure at $1.8 million, down 31.33% from the prior year.
  • Amortization of Deferred Charges for Q1 2026 stood at $275000.0, down from $662000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for GLAS reached as high as $1.6 million in Q4 2023 and fell as low as -$82114.0 in Q2 2022.
  • Historically, Amortization of Deferred Charges has averaged $440196.3 across 5 years, with a median of $345898.0 in 2023.
  • On a YoY basis, Amortization of Deferred Charges climbed as much as 36731.74% in 2022 and fell as far as 56923.61% in 2022.
  • Year by year, Amortization of Deferred Charges stood at $24746.0 in 2022, then surged by 6208.28% to $1.6 million in 2023, then decreased by 13.07% to $1.4 million in 2024, then sank by 51.22% to $662000.0 in 2025, then tumbled by 58.46% to $275000.0 in 2026.
  • Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $275000.0 in Q1 2026, $662000.0 in Q4 2025, and $250000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 275,000.00
Mar 31, 2026 275,000.00
Dec 31, 2025 662,000.00
Dec 31, 2025 662,000.00
Sep 30, 2025 250,000.00
Sep 30, 2025 250,000.00
Jun 30, 2025 430,000.00
Jun 30, 2025 430,000.00
Mar 31, 2025 418,000.00
Mar 31, 2025 418,000.00
Dec 31, 2024 1.36 Mn
Dec 31, 2024 1.36 Mn
Sep 30, 2024 414,000.00
Sep 30, 2024 414,000.00
Jun 30, 2024 402,000.00
Jun 30, 2024 402,000.00
Mar 31, 2024 390,000.00
Mar 31, 2024 390,000.00
Dec 31, 2023 1.56 Mn
Dec 31, 2023 1.56 Mn